Can an injection provide an alternative to medication for premature ejaculation?
For millions of men searching for premature ejaculation treatment, the traditional options have included behavioral therapy, topical numbing medications, counseling, and oral medications.
Now, new research is examining a very different approach: hyaluronic acid (HA) injection into the glans penis.
A 2026 randomized controlled trial directly compared glans hyaluronic acid injections with dapoxetine, a short-acting medication used internationally for premature ejaculation.
The results are noteworthy.
Both treatments improved premature ejaculation, but the men treated with glans hyaluronic acid demonstrated significantly greater improvements in ejaculation time, ejaculatory control, sexual function, quality of life, and treatment satisfaction through six months.
For men looking for a premature ejaculation specialist, an alternative to PE medication, or a longer-lasting approach to improving ejaculatory control, this study represents an important development in male sexual medicine.
What Is Premature Ejaculation?
Premature ejaculation (PE) is one of the most common male sexual concerns.
Men with PE may experience:
- Ejaculation sooner than desired
- Difficulty controlling ejaculation
- Very short time between penetration and ejaculation
- Sexual performance anxiety
- Frustration or embarrassment
- Reduced sexual confidence
- Decreased sexual satisfaction
- Relationship or partner distress
The problem is not simply how many seconds or minutes a man lasts.
A successful premature ejaculation treatment should ideally improve ejaculatory control, sexual confidence, sexual satisfaction, and quality of life.
How Is Premature Ejaculation Traditionally Treated?
Men searching for how to last longer during sex or how to stop premature ejaculation will encounter numerous treatments.
Traditional approaches may include behavioral techniques, topical anesthetic creams or sprays, pelvic floor strategies, psychological or sex therapy, and oral medications.
One medication specifically developed for PE is dapoxetine.
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) used on demand in countries where it is approved for premature ejaculation.
Medication can be effective for appropriately selected patients, but it does not work for everyone.
This has created increasing interest in non-pill treatments for premature ejaculation.
What Is Hyaluronic Acid Treatment for Premature Ejaculation?
Hyaluronic acid is a naturally occurring substance that is widely used in injectable medical products.
In male sexual medicine, HA has been studied for both penile girth enhancement and, using a different injection technique, premature ejaculation.
For PE treatment, hyaluronic acid is strategically injected into the glans penis.
This is different from HA penile shaft enhancement, which is designed primarily to increase penile girth.
The objective of glans HA injection for PE is to modulate excessive sensitivity of the glans penis.
How Could Glans HA Help a Man Last Longer?
The glans penis contains an extensive sensory nerve supply.
One proposed mechanism of hyaluronic acid injection for premature ejaculation is that the HA creates a physical interface between superficial sensory receptors and external stimulation.
Rather than eliminating penile sensation, the goal is to potentially reduce excessive sensory stimulation while maintaining sexual function.
In appropriately selected patients, this may translate into:
- Delayed ejaculation
- Increased intravaginal ejaculation latency time
- Improved control over ejaculation
- Reduced PE-related distress
- Improved sexual satisfaction
This concept has been investigated for more than two decades, but newer randomized clinical trials are providing increasingly important evidence.
The 2026 Study: Hyaluronic Acid vs. Dapoxetine
A 2026 randomized controlled trial by Torad and colleagues directly compared deep dermal glanular hyaluronic acid injection with oral dapoxetine for men with lifelong premature ejaculation.
This is particularly important because the investigators did not simply compare HA with no treatment.
They compared HA directly with an established pharmacologic treatment for PE.
The study included 60 adult men with lifelong premature ejaculation who had not adequately responded to behavioral therapy.
The men were randomly assigned to one of two groups:
Dapoxetine group: oral dapoxetine 60 mg three times weekly.
Hyaluronic acid group: HA injection into the glans penis.
Patients were evaluated at baseline and again at 1, 3, and 6 months.
What Did the Researchers Measure?
The primary outcome was intravaginal ejaculation latency time (IELT).
IELT measures the time between vaginal penetration and ejaculation and is one of the principal objective measures used in premature ejaculation research.
But the researchers went beyond simply measuring ejaculation time.
They also evaluated:
- IELT — Intravaginal Ejaculation Latency Time
- IPE — Index of Premature Ejaculation
- IIEF-5 — International Index of Erectile Function
- Quality of life
- Patient satisfaction
- Treatment-related adverse events
This is important because PE treatment should not be judged exclusively by a stopwatch.
Ejaculatory control, erectile function, sexual satisfaction, and quality of life matter as well.
What Were the Results?
Both dapoxetine and glans HA treatment produced significant improvements compared with baseline.
However, the improvements were significantly greater in the hyaluronic acid group at 1, 3, and 6 months.
The HA-treated patients demonstrated greater improvement in:
- Intravaginal ejaculation latency time
- Premature ejaculation scores
- Erectile/sexual function measures
- Quality of life
- Patient satisfaction
Patient satisfaction was also consistently higher in the HA group throughout follow-up.
The investigators concluded that deep dermal glanular HA injection was more effective than oral dapoxetine in their study for improving ejaculatory control, sexual function, and quality of life in men with lifelong PE.
Why Is This Study Important?
This randomized trial addresses an important question:
Could selected men with premature ejaculation benefit from a localized treatment rather than relying exclusively on systemic medication?
For many men, PE medication can be effective.
But some patients may dislike having to plan medication around sexual activity, may experience medication-related side effects, or may simply prefer a treatment that does not require taking a pill before intercourse.
Glans HA represents a fundamentally different strategy.
Instead of attempting to modify ejaculation through the central nervous system, HA treatment targets penile sensory input at the level of the glans.
That distinction makes this an especially interesting development in sexual medicine.
What About Side Effects?
No medical treatment is without potential adverse effects.
In the 2026 study, adverse events in the dapoxetine group included:
- Nausea
- Dizziness
- Headache
- Dry mouth
Adverse events associated with glans HA included:
- Temporary injection-site discomfort
- Bruising
- Bullae formation
As with any penile injection procedure, patients should also understand that potential complications can extend beyond those observed in a small clinical trial.
HA injection into the penis requires detailed knowledge of penile anatomy, vascular anatomy, sensory anatomy, tissue planes, and appropriate injection technique.
Is This the First Study of Hyaluronic Acid for Premature Ejaculation?
No.
Research into glans augmentation with hyaluronic acid for premature ejaculation has existed for more than 20 years.
Earlier studies reported improvements in ejaculation latency and patient satisfaction following HA injection.
A randomized placebo-controlled crossover study subsequently compared glans HA injection with saline. At one month, median IELT increased approximately 2.6-fold after HA, compared with approximately 1.1-fold after saline.
More recently, systematic reviews and additional prospective studies have continued to evaluate HA for PE.
The 2026 study adds something particularly valuable to this literature:
a randomized head-to-head comparison between HA and an oral PE medication.
Does This Mean HA Is Better Than Medication for Everyone?
No.
This is an important distinction.
The 2026 trial involved only 60 men, specifically patients with lifelong premature ejaculation that had not adequately responded to behavioral therapy.
The findings are promising, but one randomized trial does not establish that HA should replace medication as the standard treatment for every patient with premature ejaculation.
Larger studies, longer follow-up, standardized injection protocols, and additional head-to-head trials are still needed.
Premature ejaculation is also not a single disease with one cause.
The best treatment depends upon why the patient is ejaculating prematurely.
Lifelong vs. Acquired Premature Ejaculation
Before considering any PE treatment, it is important to determine whether the problem is lifelong or acquired.
A man who has experienced very rapid ejaculation since his earliest sexual experiences may be fundamentally different from a man who previously had normal ejaculatory control and suddenly develops PE later in life.
Acquired premature ejaculation can sometimes be associated with other conditions, including:
- Erectile dysfunction
- Performance anxiety
- Relationship factors
- Prostatitis or pelvic symptoms
- Endocrine or hormonal abnormalities
- Changes in penile sensitivity
- Medication or substance effects
Simply injecting the glans without determining the underlying problem would therefore be inappropriate.
Who Might Consider Glans HA for Premature Ejaculation?
Potential candidates may include appropriately evaluated men with persistent PE who:
- Have lifelong premature ejaculation
- Have excessive glans sensitivity
- Have failed behavioral treatment
- Have inadequate results from conventional PE therapy
- Cannot tolerate medication side effects
- Prefer an alternative to repeated oral medication
- Want to discuss minimally invasive PE treatment options
A consultation should determine whether glans sensitivity actually appears to be an important component of the patient’s premature ejaculation.
Hyaluronic Acid vs. Dapoxetine: Two Very Different Strategies
The comparison is particularly interesting because these treatments approach PE from opposite directions.
Dapoxetine is a systemic medication that acts through serotonin pathways involved in ejaculation.
Glans hyaluronic acid is a localized treatment intended to modify sensory stimulation at the penis.
Neither approach should automatically be considered appropriate for every patient.
The question should not simply be:
“Which treatment is better?”
The more useful question is:
“Which treatment best addresses the mechanism of premature ejaculation in this particular patient?”
Glans HA and Penile Enhancement
There is another potential advantage of glans HA that some patients may find interesting.
Hyaluronic acid can also increase glans circumference and improve glans volume.
This means glans HA occupies a unique position at the intersection of male enhancement and sexual function.
For selected patients, treatment may potentially address both glans aesthetics and excessive penile sensitivity.
This should not be confused with HA penile girth enhancement of the shaft, where filler is distributed in different anatomical planes primarily to increase penile circumference and improve contour.
The two procedures can potentially complement each other, but they have different objectives and require different techniques.
Penile Self-Image, Sexual Confidence, and Premature Ejaculation
This discussion becomes even more interesting when we consider recent research into male genital self-image.
A 2024 study published in Sexual Medicine found a significant association between poorer male genital self-image and premature ejaculation.
Men with PE reported greater dissatisfaction with genital size and function, sexual experiences, and aspects of body image.
This does not mean that penile enlargement cures premature ejaculation.
It does suggest that penile appearance, genital self-image, sexual confidence, performance anxiety, and sexual function can interact in complex ways.
Modern male sexual medicine should therefore consider both function and self-perception.
A New Direction in Premature Ejaculation Treatment
The treatment of premature ejaculation is evolving.
Behavioral therapy and medication remain important options, but emerging treatments are beginning to target the peripheral mechanisms of ejaculation more directly.
Glans hyaluronic acid injection is one of the most interesting of these approaches.
The 2026 randomized trial provides new evidence that, in appropriately selected men with lifelong PE, glans HA may produce meaningful improvements in ejaculation latency, ejaculatory control, sexual function, quality of life, and treatment satisfaction.
It is promising evidence—not the final word.
Looking for a Premature Ejaculation Specialist?
If you are searching for:
premature ejaculation treatment, PE treatment, how to last longer in bed, how to delay ejaculation, premature ejaculation injections, hyaluronic acid for premature ejaculation, glans HA injection, glans enhancement, alternatives to dapoxetine, alternatives to PE medication, nonsurgical premature ejaculation treatment, or advanced male sexual medicine treatments, the first step should be a comprehensive evaluation.
The objective is not simply to make intercourse last longer.
The goal is better ejaculatory control, preserved sensation and erectile function, improved sexual confidence, and greater satisfaction for both the patient and his partner.
Treatment should be individualized based on the type of premature ejaculation, penile sensitivity, erectile function, anatomy, previous treatments, expectations, and overall sexual health.
References
Torad H, Rammah AM, Elahwany A, et al. Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation. International Urology and Nephrology. Published online July 20, 2026.
Elahwany A, et al. Hyaluronic acid injection in glans penis for treatment of premature ejaculation: a randomized controlled cross-over study.
Koçak V, Tufan O. Male genital self-image, premature ejaculation, and affecting factors. Sex Med. 2024;12(3).
Additional prospective studies and systematic reviews have evaluated glans hyaluronic acid injection for premature ejaculation, ejaculation latency, patient satisfaction, and sexual-function outcomes.
Medical Disclaimer
This article is provided for educational purposes and does not constitute individual medical advice. Glans hyaluronic acid injection for premature ejaculation is an emerging, specialized treatment and may represent off-label use depending on the HA product, jurisdiction, and indication. Results vary. Potential risks include pain, swelling, bruising, contour changes, nodules, infection, vascular complications, altered sensation, and other adverse events. Current evidence is promising but remains limited, and larger studies with longer follow-up are needed. Patients should undergo evaluation by a physician experienced in male sexual medicine and penile anatomy before considering treatment.
